全球吸入一氧化氮市場規模研究，依應用（新生兒呼吸治療、慢性阻塞性肺病、急性呼吸窘迫症候群等）及 2022-2032 年區域預測

2023年全球吸入一氧化氮市場價值約為11.2億美元，預計在2024-2032年預測期內將以超過7.70%的健康成長率成長。吸入一氧化氮 (iNO) 是一種醫用氣體，用作治療劑，用於改善面臨某些呼吸困難的個體的氧合作用。它的作用是擴張肺部血管，促進血液更好地流向有效氧氣交換所必需的區域。一氧化氮是體內自然產生的分子，具有舒張血管和調節血壓的作用。 。 iNO 針對肺部富氧區域周圍的血管，促進放鬆和增加血流量，以促進紅血球最佳的氧氣攝取。這種針對性的行動對於治療新生兒呼吸治療、慢性阻塞性肺病、急性呼吸窘迫症候群等疾病至關重要。因此，iNO 在管理血管和氧合問題方面發揮著至關重要的作用，特別是在新生兒和重症監護情況下。支持 iNO 治療成人療效和安全性的強力的臨床證據是支持全球吸入一氧化氮市場成長的關鍵趨勢。

由於嬰兒和新生兒肺部疾病治療方法的增加，加上呼吸系統疾病盛行率的上升和醫療基礎設施的進步，吸入一氧化氮市場的成長預計將大幅成長。此外，人們越來越認知到吸入一氧化氮在治療各種肺部疾病（尤其是新生兒）方面的有效性，這支持了預計 2024 年至 2032 年期間的市場擴張。例如，國家心肺血液研究所2022 年的一篇文章強調了影響新生兒的一系列呼吸問題，包括短暫性呼吸急促、新生兒呼吸窘迫症候群(RDS)、新生兒持續性肺動脈高壓(PPHN)、胎糞吸入症候群和支氣管肺發育不良（BPD）。 PPHN 是一種以肺血管阻力增高為特徵的危重病症，是吸入一氧化氮治療的主要適應症。其機制涉及選擇性擴張肺血管、增強氧合和減少對侵入性通氣方法的依賴。此外，美國食品藥物管理局批准吸入一氧化氮治療缺氧性呼吸衰竭，進一步促進了其應用。因此，為了控制新生兒呼吸系統併發症而採用吸入一氧化氮的激增，將推動吸入一氧化氮市場的預期成長。此外，預計針對吸入一氧化氮的深入研究和開發活動將為這種治療氣體的市場帶來巨大的成長機會。吸入一氧化氮因其在一系列肺部和心血管疾病方面的治療潛力而引起了人們極大的興趣。醫學科學和技術的不斷進步刺激了吸入一氧化氮的創新應用和配方的研究，促使製藥公司和研究機構增加對研發的投資。這些措施旨在改善輸送機制、劑量方案並擴大吸入一氧化氮治療的適應症範圍。然而，各個地區嚴格的應用規範以及該程序產生的高成本預計將阻礙 2022 年至 2032 年的市場成長。

全球吸入一氧化氮市場研究涵蓋的關鍵區域包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。到 2023 年，北美將成為吸入式一氧化氮市場的主導地區，預計將在整個預測期內以最高的市場佔有率保持領先地位。先進醫療設施的存在和大量醫療保健支出水平等關鍵因素促進了吸入一氧化氮等創新治療方法的採用，這些因素主要推動了區域市場的成長。此外，北美受益於廣泛的研究和開發計劃，加上有利的監管環境，促進了該地區吸入一氧化氮產品的進步和商業可用性。然而，由於慢性阻塞性肺病（COPD）、肺動脈高壓和新生兒缺氧性呼吸衰竭等呼吸系統疾病的盛行率不斷上升，預計亞太地區的市場在預測期內將以最快的速度成長。

本報告中包括的主要市場參與者有：

• 液化空氣醫療保健（法國）
• SOL集團（義大利）
• Matheson Tri-Gas Inc.（美國）
• 默克公司（德國）
• Mallinckrodt 製藥公司（英國）
• Nu-Med Plus Inc.（美國）
• 博純有限責任公司（美國）
• 普萊克斯分銷公司（美國）
• 豪邁集團（英國）
• 林德集團（德國）

目錄

第 1 章：全球吸入一氧化氮市場定義與研究假設

• 研究目的
• 市場定義
• 研究假設
  • 包容與排除
  • 限制
  • 供給側分析
    • 可用性
    • 基礎設施
    • 監管環境
    • 市場競爭
    • 經濟可行性（消費者的角度）
  • 需求面分析
    • 監理框架
    • 技術進步
    • 環境考慮
    • 消費者意識和接受度
• 估算方法
• 研究涵蓋的年份
• 貨幣兌換率

第 2 章：執行摘要

• 全球吸入一氧化氮市場規模及預測（2022-2032）
• 區域概要
• 分部摘要
  • 按申請
• 主要趨勢
• 經濟衰退的影響
• 分析師推薦與結論

第 3 章：全球吸入一氧化氮市場動態

• 市場促進因素
• 市場挑戰
• 市場機會

第 4 章：全球吸入一氧化氮市場：產業分析

• 波特的五力模型
  • 供應商的議價能力
  • 買家的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭競爭
  • 波特五力模型的未來方法
  • 波特的 5 力影響分析
• PESTEL分析
  • 政治的
  • 經濟的
  • 社會的
  • 技術性
  • 環境的
  • 合法的
• 頂級投資機會
• 最佳制勝策略
• 顛覆性趨勢
• 產業專家視角
• 分析師推薦與結論

第 5 章：2022-2032 年全球吸入一氧化氮市場規模及應用預測

• 新生兒呼吸治療
• 慢性阻塞性肺臟疾病
• 急性呼吸窘迫症候群
• 其他

第 6 章：2022-2032 年全球吸入一氧化氮市場規模及按地區預測

• 北美吸入一氧化氮市場
  • 美國吸入一氧化氮市場
    • 2022-2032 年應用細分規模與預測
  • 加拿大吸入一氧化氮市場
• 歐洲吸入一氧化氮市場
  • 英國吸入一氧化氮市場
  • 德國吸入一氧化氮市場
  • 法國吸入一氧化氮市場
  • 西班牙吸入一氧化氮市場
  • 義大利吸入一氧化氮市場
  • 歐洲其他地區吸入一氧化氮市場
• 亞太地區吸入一氧化氮市場
  • 中國吸入一氧化氮市場
  • 印度吸入一氧化氮市場
  • 日本吸入一氧化氮市場
  • 澳洲吸入一氧化氮市場
  • 韓國吸入一氧化氮市場
  • 亞太地區其他地區吸入一氧化氮市場
• 拉丁美洲吸入一氧化氮市場
  • 巴西吸入一氧化氮市場
  • 墨西哥吸入一氧化氮市場
  • 拉丁美洲其他地區吸入一氧化氮市場
• 中東和非洲吸入一氧化氮市場
  • 沙烏地阿拉伯吸入一氧化氮市場
  • 南非吸入一氧化氮市場
  • 中東和非洲其他地區吸入一氧化氮市場

第 7 章：競爭情報

• 重點企業SWOT分析
• 頂級市場策略
• 公司簡介
  • Air Liquide Healthcare (France)
  • 關鍵訊息
  • 概述
  • 財務（視數據可用性而定）
  • 產品概要
  • 市場策略
  • SOL Group (Italy)
  • Matheson Tri-Gas Inc. (United States)
  • Merck KGaA (Germany)
  • Mallinckrodt Pharmaceuticals (United Kingdom)
  • Nu-Med Plus Inc. (United States)
  • Perma Pure LLC (United States)
  • Praxair Distribution Inc. (United States)
  • HALMA PLC (United Kingdom)
  • LINDE PLC (Germany)

第 8 章：研究過程

• 研究過程
  • 資料探勘
  • 分析
  • 市場預測
  • 驗證
  • 出版
• 研究屬性

Global Inhaled Nitric Oxide Market is valued approximately at USD 1.12 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.70% over the forecast period 2024-2032. Inhaled nitric oxide (iNO) is a medical gas used as a therapeutic agent to improve oxygenation in individuals facing certain respiratory difficulties. It works by expanding blood vessels in the lungs, promoting better blood flow to areas essential for effective oxygen exchange. Nitric oxide is a naturally produced molecule in the body, playing a role in vasodilation and regulating blood pressure. . iNO targets blood vessels surrounding oxygen-rich areas in the lungs, promoting relaxation and heightened blood flow to facilitate optimal oxygen uptake by red blood cells. This targeted action is essential in treating conditions such as neonatal respiratory treatment, chronic obstructive pulmonary disease, acute respiratory distress syndrome, others. Accordingly, iNO plays a vital role in managing vascular and oxygenation issues, especially in neonatal and critical care scenarios. The robust clinical evidence supporting the efficacy and safety of iNO therapy in adults is a key trend supporting the growth of the Global Inhaled Nitric Oxide Market.

The growth of the inhaled nitric oxide market is anticipated to surge significantly due to increased adoption for managing pulmonary disorders in infants and newborns, coupled with a rise in respiratory disorders prevalence and advancements in healthcare infrastructure. Also, there is growing awareness regarding inhaled nitric oxide's effectiveness in treating various pulmonary conditions, especially in neonates, which is supporting the market expansion during the estimated period of 2024-2032. For instance, a 2022 article from the National Heart, Lung, and Blood Institute highlights the range of breathing problems affecting newborns, including transient tachypnea, neonatal respiratory distress syndrome (RDS), persistent pulmonary hypertension of the newborn (PPHN), meconium aspiration syndrome, and bronchopulmonary dysplasia (BPD). PPHN is a critical condition marked by heightened pulmonary vascular resistance is a primary indication for inhaled nitric oxide therapy. Its mechanism involves selective dilation of pulmonary blood vessels, enhancing oxygenation, and reducing reliance on invasive ventilation methods. Furthermore, the U.S. Food and Drug Administration's approval for inhaled nitric oxide in treating hypoxic respiratory failure further bolsters its adoption. Consequently, the surge in adoption of inhaled nitric oxide in order to manage respiratory complications in newborns is poised to drive the projected growth of the inhaled nitric oxide market. Furthermore, intensive research and development activities focused on inhaled nitric oxide are anticipated to present substantial growth opportunities within the market for this therapeutic gas. Inhaled nitric oxide has attracted considerable interest due to its promising therapeutic potential across a spectrum of pulmonary and cardiovascular conditions. The ongoing progress in medical science and technology has spurred investigations into innovative applications and formulations of inhaled nitric oxide, prompting heightened investments in research and development by pharmaceutical firms and research establishments. These initiatives aim to refine delivery mechanisms, dosage protocols, and broaden the scope of indications for inhaled nitric oxide therapy. However, stringent application norms across various regions, along with high costs incurred with the procedure is expected to hinder the market growth between 2022 and 2032.

The key regions considered for the global Inhaled Nitric Oxide Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America is a dominating region in the inhaled nitric oxide market and is projected to sustain its leading position with the highest number of market shares throughout the forecast period. Key factors such as presence of advanced healthcare facilities and substantial healthcare expenditure levels that facilitate the adoption of innovative treatments like inhaled nitric oxide are primarily bolstering the regional market growth. Moreover, North America benefits from extensive research and development initiatives, coupled with a favorable regulatory landscape, which have fostered the advancement and commercial availability of inhaled nitric oxide products in the region. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period owing to the rising prevalence of respiratory conditions such as chronic obstructive pulmonary disease (COPD), pulmonary hypertension, and neonatal hypoxic respiratory failure.

Major market player included in this report are:

• Air Liquide Healthcare (France)
• SOL Group (Italy)
• Matheson Tri-Gas Inc. (United States)
• Merck KGaA (Germany)
• Mallinckrodt Pharmaceuticals (United Kingdom)
• Nu-Med Plus Inc. (United States)
• Perma Pure LLC (United States)
• Praxair Distribution Inc. (United States)
• HALMA PLC (United Kingdom)
• LINDE PLC (Germany)

The detailed segments and sub-segment of the market are explained below:

By Application

• Neonatal Respiratory Treatment
• Chronic Obstructive Pulmonary Disease
• Acute Respiratory Distress Syndrome
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1.Global Inhaled Nitric Oxide Market Definition and Research Assumptions

• 1.1.Research Objective
• 1.2.Market Definition
• 1.3.Research Assumptions
  • 1.3.1.Inclusion & Exclusion
  • 1.3.2.Limitations
  • 1.3.3.Supply Side Analysis
    • 1.3.3.1.Availability
    • 1.3.3.2.Infrastructure
    • 1.3.3.3.Regulatory Environment
    • 1.3.3.4.Market Competition
    • 1.3.3.5.Economic Viability (Consumer's Perspective)
  • 1.3.4.Demand Side Analysis
    • 1.3.4.1.Regulatory frameworks
    • 1.3.4.2.Technological Advancements
    • 1.3.4.3.Environmental Considerations
    • 1.3.4.4.Consumer Awareness & Acceptance
• 1.4.Estimation Methodology
• 1.5.Years Considered for the Study
• 1.6.Currency Conversion Rates

Chapter 2.Executive Summary

• 2.1.Global Inhaled Nitric Oxide Market Size & Forecast (2022- 2032)
• 2.2.Regional Summary
• 2.3.Segmental Summary
  • 2.3.1.By Application
• 2.4.Key Trends
• 2.5.Recession Impact
• 2.6.Analyst Recommendation & Conclusion

Chapter 3.Global Inhaled Nitric Oxide Market Dynamics

• 3.1.Market Drivers
• 3.2.Market Challenges
• 3.3.Market Opportunities

Chapter 4.Global Inhaled Nitric Oxide Market: Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
  • 4.1.6.Futuristic Approach to Porter's 5 Force Model
  • 4.1.7.Porter's 5 Force Impact Analysis
• 4.2.PESTEL Analysis
  • 4.2.1.Political
  • 4.2.2.Economic
  • 4.2.3.Social
  • 4.2.4.Technological
  • 4.2.5.Environmental
  • 4.2.6.Legal
• 4.3.Top investment opportunity
• 4.4.Top winning strategies
• 4.5.Disruptive Trends
• 4.6.Industry Expert Perspective
• 4.7.Analyst Recommendation & Conclusion

Chapter 5.Global Inhaled Nitric Oxide Market Size & Forecasts by Application 2022-2032

• 5.1.Neonatal Respiratory Treatment
• 5.2.Chronic Obstructive Pulmonary Disease
• 5.3.Acute Respiratory Distress Syndrome
• 5.4.Others

Chapter 6.Global Inhaled Nitric Oxide Market Size & Forecasts by Region 2022-2032

• 6.1.North America Inhaled Nitric Oxide Market
  • 6.1.1.U.S. Inhaled Nitric Oxide Market
    • 6.1.1.1. Application breakdown size & forecasts, 2022-2032
  • 6.1.2.Canada Inhaled Nitric Oxide Market
• 6.2.Europe Inhaled Nitric Oxide Market
  • 6.2.1.U.K. Inhaled Nitric Oxide Market
  • 6.2.2.Germany Inhaled Nitric Oxide Market
  • 6.2.3.France Inhaled Nitric Oxide Market
  • 6.2.4.Spain Inhaled Nitric Oxide Market
  • 6.2.5.Italy Inhaled Nitric Oxide Market
  • 6.2.6.Rest of Europe Inhaled Nitric Oxide Market
• 6.3.Asia-Pacific Inhaled Nitric Oxide Market
  • 6.3.1.China Inhaled Nitric Oxide Market
  • 6.3.2.India Inhaled Nitric Oxide Market
  • 6.3.3.Japan Inhaled Nitric Oxide Market
  • 6.3.4.Australia Inhaled Nitric Oxide Market
  • 6.3.5.South Korea Inhaled Nitric Oxide Market
  • 6.3.6.Rest of Asia Pacific Inhaled Nitric Oxide Market
• 6.4.Latin America Inhaled Nitric Oxide Market
  • 6.4.1.Brazil Inhaled Nitric Oxide Market
  • 6.4.2.Mexico Inhaled Nitric Oxide Market
  • 6.4.3.Rest of Latin America Inhaled Nitric Oxide Market
• 6.5.Middle East & Africa Inhaled Nitric Oxide Market
  • 6.5.1. Saudi Arabia Inhaled Nitric Oxide Market
  • 6.5.2. South Africa Inhaled Nitric Oxide Market
  • 6.5.3.Rest of Middle East & Africa Inhaled Nitric Oxide Market

Chapter 7.Competitive Intelligence

• 7.1.Key Company SWOT Analysis
• 7.2.Top Market Strategies
• 7.3.Company Profiles
  • 7.3.1.Air Liquide Healthcare (France)
    • 7.3.1.1.Key Information
    • 7.3.1.2.Overview
    • 7.3.1.3.Financial (Subject to Data Availability)
    • 7.3.1.4.Product Summary
    • 7.3.1.5.Market Strategies
  • 7.3.2.SOL Group (Italy)
  • 7.3.3.Matheson Tri-Gas Inc. (United States)
  • 7.3.4.Merck KGaA (Germany)
  • 7.3.5.Mallinckrodt Pharmaceuticals (United Kingdom)
  • 7.3.6.Nu-Med Plus Inc. (United States)
  • 7.3.7.Perma Pure LLC (United States)
  • 7.3.8.Praxair Distribution Inc. (United States)
  • 7.3.9.HALMA PLC (United Kingdom)
  • 7.3.10.LINDE PLC (Germany)

Chapter 8.Research Process

• 8.1.Research Process
  • 8.1.1.Data Mining
  • 8.1.2.Analysis
  • 8.1.3.Market Estimation
  • 8.1.4.Validation
  • 8.1.5.Publishing
• 8.2.Research Attributes

LIST OF TABLES

• TABLE 1.Global Inhaled Nitric Oxide Market, report scope
• TABLE 2.Global Inhaled Nitric Oxide Market estimates & forecasts by Region 2022-2032 (USD Billion)
• TABLE 3.Global Inhaled Nitric Oxide Market estimates & forecasts by Application 2022-2032 (USD Billion)
• TABLE 4.Global Inhaled Nitric Oxide Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 5.Global Inhaled Nitric Oxide Market by region, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 6.Global Inhaled Nitric Oxide Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 7.Global Inhaled Nitric Oxide Market by region, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 8.Global Inhaled Nitric Oxide Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 9.Global Inhaled Nitric Oxide Market by region, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 10.Global Inhaled Nitric Oxide Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 11.Global Inhaled Nitric Oxide Market by region, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 12.Global Inhaled Nitric Oxide Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 13.Global Inhaled Nitric Oxide Market by region, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 14.U.S. Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 15.U.S. Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 16.U.S. Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 17.Canada Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 18.Canada Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 19.Canada Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 20.UK Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 21.UK Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 22.UK Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 23.Germany Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 24.Germany Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 25.Germany Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 26.France Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 27.France Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 28.France Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 29.Italy Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 30.Italy Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 31.Italy Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 32.Spain Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 33.Spain Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 34.Spain Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 35.RoE Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 36.RoE Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 37.RoE Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 38.China Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 39.China Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 40.China Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 41.India Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 42.India Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 43.India Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 44.Japan Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 45.Japan Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 46.Japan Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 47.Australia Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 48.Australia Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 49.Australia Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 50.South Korea Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 51.South Korea Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 52.South Korea Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 53.
• TABLE 54.RoAPAC Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 55.RoAPAC Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 56.RoAPAC Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 57.Brazil Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 58.Brazil Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 59.Brazil Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 60.Mexico Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 61.Mexico Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 62.Mexico Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 63.RoLA Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 64.RoLA Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 65.RoLA Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 66.Saudi Arabia Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 67.Saudi Arabia Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 68.Saudi Arabia Inhaled Nitric Oxide Market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 69.South Africa Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 70.
• TABLE 71.South Africa Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 72.South Africa Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 73.RoMEA Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 74.RoMEA Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 75.RoMEA Inhaled Nitric Oxide Market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 76.List of secondary sources, used in the study of Global Inhaled Nitric Oxide Market.
• TABLE 77.List of primary sources, used in the study of Global Inhaled Nitric Oxide Market.
• TABLE 78.Years considered for the study.
• TABLE 79.Exchange rates considered.

LIST OF FIGURES

• FIG 1.Global Inhaled Nitric Oxide Market, research methodology
• FIG 2.Global Inhaled Nitric Oxide Market, market estimation techniques
• FIG 3.Global market size estimates & forecast methods.
• FIG 4.Global Inhaled Nitric Oxide Market, key trends 2023
• FIG 5.Global Inhaled Nitric Oxide Market, growth prospects 2022-2032
• FIG 6.Global Inhaled Nitric Oxide Market, porters 5 force model
• FIG 7.Global Inhaled Nitric Oxide Market, pestel analysis
• FIG 8.Global Inhaled Nitric Oxide Market, value chain analysis
• FIG 9.Global Inhaled Nitric Oxide Market by segment, 2022 & 2032 (USD Billion)
• FIG 10.Global Inhaled Nitric Oxide Market by segment, 2022 & 2032 (USD Billion)
• FIG 11.Global Inhaled Nitric Oxide Market by segment, 2022 & 2032 (USD Billion)
• FIG 12.Global Inhaled Nitric Oxide Market by segment, 2022 & 2032 (USD Billion)
• FIG 13.Global Inhaled Nitric Oxide Market by segment, 2022 & 2032 (USD Billion)
• FIG 14.Global Inhaled Nitric Oxide Market, regional snapshot 2022 & 2032
• FIG 15.North America Inhaled Nitric Oxide Market 2022 & 2032 (USD Billion)
• FIG 16.Europe Inhaled Nitric Oxide Market 2022 & 2032 (USD Billion)
• FIG 17.Asia pacific Inhaled Nitric Oxide Market 2022 & 2032 (USD Billion)
• FIG 18.Latin America Inhaled Nitric Oxide Market 2022 & 2032 (USD Billion)
• FIG 19.Middle East & Africa Inhaled Nitric Oxide Market 2022 & 2032 (USD Billion)
• FIG 20.Global Inhaled Nitric Oxide Market, company market share analysis (2023)